cell-therapy
No description yet: the sentence for this tag has not been written. 11 records carry it: 11 people.
Related tags
11 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Caron A. Jacobson Lymphoma specialist and medical director of immune effector cell therapy, Dana-Farber Cancer Institute · Dana-Farber Brigham Cancer Center Boston lymphoma doctor who led ZUMA-5, the trial that brought the CAR-T therapy axicabtagene ciloleucel to relapsed follicular lymphoma. | Follicular lymphoma, Marginal zone lymphoma, Non-Hodgkin lymphoma | none | lymphoma, car-t, trialist | ||
Inge Marie Svane Director, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital Herlev · Herlev Hospital, Copenhagen University Hospital Led the Dutch-Danish trial that proved TIL therapy beats ipilimumab in melanoma, the first randomised win for a cell therapy in a solid tumour. | Melanoma | none | til, melanoma | ||
Katayoun Rezvani Professor of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center · MD Anderson Cancer Center Created cord blood-derived CAR-NK cells, the first off-the-shelf CAR cell therapy to show remissions in lymphoma. | Chronic lymphocytic leukaemia, Diffuse large B-cell lymphoma | none | nk-cells, off-the-shelf | ||
Marcela V. Maus Director, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center; Professor, Harvard Medical School · Massachusetts General Hospital Cancer Center Cell therapy engineer whose CAR-TEAM cells produced rapid regressions of recurrent glioblastoma. | Glioma & glioblastoma | none | car-t, solid-tumours | ||
Michel Sadelain Director, Columbia Initiative in Cell Engineering and Therapy, Columbia University Irving Medical Center · Herbert Irving Comprehensive Cancer Center, Columbia University Designed the second-generation CAR with a CD28 costimulatory domain that made CAR-T therapy work. | Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma | none | car-t, engineering | ||
Robbie G. Majzner Director of Solid Tumor Immunotherapy, Department of Oncology, St. Jude Children's Research Hospital · St. Jude Children's Research Hospital Led the GD2 CAR-T trial in diffuse midline glioma and defined antigen density as a barrier to CAR-T in solid tumours. | Neuroblastoma, Osteosarcoma | none | car-t, paediatric | ||
Sandra P. D'Angelo Medical Oncologist, Sarcoma and Melanoma Services, Memorial Sloan Kettering Cancer Center · Memorial Sloan Kettering Cancer Center Led SPEARHEAD-1, the trial that made afami-cel the first engineered TCR T-cell therapy approved for a solid tumour. | Sarcomas, Merkel cell carcinoma | none | sarcoma, tcr-t | ||
Sattva S. Neelapu Professor and Deputy Chair, Department of Lymphoma and Myeloma, MD Anderson Cancer Center · MD Anderson Cancer Center Led ZUMA-1, the trial that made axicabtagene ciloleucel the first CAR-T therapy approved for lymphoma. | Diffuse large B-cell lymphoma, Follicular lymphoma | none | lymphoma, car-t | ||
Stephan A. Grupp Chief, Cellular Therapy and Transplant Section, Children's Hospital of Philadelphia; Professor of Pediatrics, University of Pennsylvania · Children's Hospital of Philadelphia Treated the first child with CAR-T cells and led ELIANA, the trial behind the first CAR-T approval. | Acute lymphoblastic leukaemia | none | car-t, paediatric | ||
Stephen J. Schuster Robert and Margarita Louis-Dreyfus Professor in CLL and Lymphoma, Abramson Cancer Center, University of Pennsylvania · Abramson Cancer Center, University of Pennsylvania Led JULIET, which brought tisagenlecleucel, the first CAR-T, to adults with relapsed large B-cell lymphoma. | Diffuse large B-cell lymphoma, Follicular lymphoma | none | lymphoma, car-t | ||
Waseem Qasim Professor of Cell and Gene Therapy, UCL Great Ormond Street Institute of Child Health · Great Ormond Street Hospital for Children Delivered the first gene-edited off-the-shelf CAR-T cells to infants with leukaemia and the first base-edited CAR-T therapy. | Acute lymphoblastic leukaemia | none | gene-editing, paediatric |
